Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion type Assertion NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_head.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion description "[When compared with their CD133? counterparts, CD133(+) cells not only possess the preferential ability to form undifferentiated tumor spheroids in vitro but also express an enhanced level of stem cell-associated genes, have a greater ability to form tumors when implanted orthotopically in immunodeficient mice, and can be serially passaged into secondary animal recipients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion evidence source_evidence_literature NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion SIO_000772 21112564 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion wasDerivedFrom befree-20140225 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.
- NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_assertion wasGeneratedBy ECO_0000203 NP718744.RA2PzaO5tZxYoGPxmSlAz1e3OHwK94fHe0SOhMMjwE-JE130_provenance.